Research in Real-World Settings: PCORI s Model for Comparative Clinical Effectiveness Research

Similar documents
A Framework for Patient-Centered Outcomes Research

Clinically Meaningful Inclusion of Participants in Clinical Trials. David Hickam, MD, MPH Washington, DC April 9, 2015

Presenters: Robin Newhouse Steven Goodman David Hickam

Accelerating Patient-Centered Outcomes Research and Methodological Research

The Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved

Introduction to the Patient- Centered Outcomes Research Institute

The PCORI Methodology Standards Academic Curriculum TEACHING GUIDE

PCORI s Role in Supporting CER

Treatment of Multiple Sclerosis

Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH

Chapter 2 Comparative Effectiveness Research

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Observational Studies and PCOR: What are the right questions?

Pros and Cons of Clinical Trials vs. Observational Studies. Beth Devine PCORP Summer Institute July 14, 2015

Pragmatic Trials: What the Heck Are They and Why Should You Care?

Overview of Study Designs in Clinical Research

Guideline Development At WHO

Overview of Study Designs

Choosing the right study design

On the Utility of Subgroup Analyses in Confirmatory Clinical Trials

Lia Hotchkiss: I'm Lia Hotchkiss and I'm with the Agency for Healthcare. Research and Quality. We are one of the 12 agencies part of the Department of

Penn State MPH Program Competencies 2013

Chapter 17 Sensitivity Analysis and Model Validation

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017

Selecting a research method

Challenges of Observational and Retrospective Studies

Appraising the Literature Overview of Study Designs

Study Designs in Epidemiology

Pragmatic Clinical Trials. Disclosure/Conflict of Interest. Learning Objectives 7/15/2015. Friedly: No disclosures

PCORI Funding Announcement: Assessment of Prevention, Diagnosis, and Treatment Options

Nature and significance of the local problem

Systematic Reviews and Meta-analysis

Comparative Effectiveness in Health Care Reform. Carrie Hoverman Colla, Ph.D. Dartmouth Medical School Norris Cotton Cancer Center

Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002

Conduct Rigorous and Scientific Research. Chang Xu Department of Computer Science and Technology Nanjing University Sep 21, 2018

DEPARTMENT OF EPIDEMIOLOGY 2. BASIC CONCEPTS

Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies relying on Healthcare Databases

Project Funded under FP7 - HEALTH Grant Agreement no Funded under FP7 - HEALTH Grant Agreement no

Objectives. Information proliferation. Guidelines: Evidence or Expert opinion or???? 21/01/2017. Evidence-based clinical decisions

Systematic Reviews and Meta- Analysis in Kidney Transplantation

Research Questions and Survey Development

Quantitative challenges of extrapolation

Analysis methods for improved external validity

Real-world data in pragmatic trials

Project Coordinator Job Description

GLOSSARY OF GENERAL TERMS

New NCCIH Funding Opportunities for Natural Product Clinical Trials. May 9, 2017

Data and Safety Monitoring in Pragmatic Clinical Trials. Susan S. Ellenberg, PhD Greg Simon, MD, MPH Jeremy Sugarman, MD, MPH, MA

95% 2.5% 2.5% +2SD 95% of data will 95% be within of data will 1.96 be within standard deviations 1.96 of sample mean

PCORI Funding Announcement: Pragmatic Clinical Studies and Large Simple Trials to Evaluate Patient-Centered Outcomes

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

Seeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making

USDA Nutrition Evidence Library: Systematic Review Methodology

Marc L. Berger, MD, 1 Muhammad Mamdani, PharmD, MA, MPH, 2 David Atkins, MD, MPH, 3 Michael L. Johnson, PhD 4. Background to the Task Force

Anatomy of Medical Studies: Part I. Emily D Agostino Epidemiology and Biostatistics CUNY School of Public Health at Hunter College

Systematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai

The PCORI Methodology Report is undergoing final revisions to reflect the updated standards. The PCORI Methodology Report. PCORI Methodology Committee

CLOSED. PCORI Funding Announcement: Assessment of Prevention, Diagnosis, and Treatment Options

5/10/2010. ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force

Module 5. The Epidemiological Basis of Randomised Controlled Trials. Landon Myer School of Public Health & Family Medicine, University of Cape Town

CLINICAL REGISTRIES Use and Emerging Best Practices

Decision Making in Confirmatory Multipopulation Tailoring Trials

U.S. Preventive Services Task Force Methods and Processes. Alex R. Kemper, MD, MPH, MS June 16, 2014

Patient-Centeredness

Design of Experiments & Introduction to Research

Complications of Proton Pump Inhibitor Therapy. Gastroenterology 2017; 153:35-48 발표자 ; F1 김선화

Summary. 20 May 2014 EMA/CHMP/SAWP/298348/2014 Procedure No.: EMEA/H/SAB/037/1/Q/2013/SME Product Development Scientific Support Department

Framework for Defining Evidentiary Standards for Biomarker Qualification: Minimal Residual Disease (MRD) in Multiple Myeloma (MM)

Data Use to Inform HIV Programs and Policies. Usma Khan, MS Hilary Spindler, MPH Prevention and Public Health Group Global Health Sciences

Big Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit

Asking & Answering Sociological Questions

Quantitative research Methods. Tiny Jaarsma

Pragmatic Trials and Comparative Effectiveness Research (CER) Sharon Straus Christine Hunter Russ Glasgow

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL?

Experimental design (continued)

OBSERVATIONAL STUDIES IN A LEARNING HEALTH SYSTEM

WWC STUDY REVIEW STANDARDS

Sandra Tilmon, MPH Research Manager The University of Chicago Clinical Directors Network, (CDN) Webcast November 9 th, 2018

Submitted to: Re: Comments on CMS Proposals for Patient Condition Groups and Care Episode Groups

Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil

OHDSI Tutorial: Design and implementation of a comparative cohort study in observational healthcare data

INTERPRETATION OF STUDY FINDINGS: PART I. Julie E. Buring, ScD Harvard School of Public Health Boston, MA

Analysis A step in the research process that involves describing and then making inferences based on a set of data.

Cancer Service Performance Indicators Round 1 Report. Integrated Cancer Services. January Department of Health

Types of Biomedical Research

Propensity Score Matching with Limited Overlap. Abstract

12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C

STUDY DESIGNS WHICH ONE IS BEST?

Bringing Together Clinical, Economic and Patient Reported Outcomes Data Future Of Real World Evidence. March IIeX Health, Philadelphia, PA

Practical and ethical advantages of Bayesian approaches in adaptive clinical trial designs. Kristian Thorlund

Definition and Purpose

TRANSLATING RESEARCH INTO PRACTICE

Beyond the intention-to treat effect: Per-protocol effects in randomized trials

Index. Springer International Publishing Switzerland 2017 T.J. Cleophas, A.H. Zwinderman, Modern Meta-Analysis, DOI /

CONSORT 2010 checklist of information to include when reporting a randomised trial*

CONCEPTUALIZING A RESEARCH DESIGN

How to craft the Approach section of an R grant application

PCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved.

Generalizing the right question, which is?

Transcription:

Research in Real-World Settings: PCORI s Model for Comparative Clinical Effectiveness Research David Hickam, MD, MPH Director, Clinical Effectiveness & Decision Science Program April 10, 2017 Welcome! David Hickam Director, Clinical Effectiveness and Decision Science Program 2 1

Overview Framework for understanding the purpose and approaches used in comparative effectiveness research (CER) Issues in designing and conducting a study to answer a CER question 3 What is evidence-based information? Clinical Evidence Valid data about the outcomes experienced by patients who receive specific medical interventions Assurance that the most important outcomes are captured and recorded Characteristics of the patients are sufficiently well-described to improve understanding about variation in outcomes across important subgroups Key Features Clinical characteristics of the study population are comparable to those of the patients to whom the evidence will be applied Clinical interventions are well-defined and reproducible Outcomes include both benefits and harms associated with the specific clinical interventions 4 2

What is PICOTS? The Population that is studied The Intervention that is delivered to some patients The Comparator that other patients receive The important patient Outcomes that are assessed The Timing of when outcomes are assessed The study s clinical Setting 5 What is the starting point of comparative effectiveness? Examine the choices people make about the options for managing a disease Consider how compelling it is to make a choice among these options Consider how the need to compare these options could inform the focus of new research Heterogeneity of the patient population Understanding the important benefits and harms Clarity about gaps in the current evidence base 6 3

Features of Patient-Centered Outcomes (PCOR) projects Project assesses whether two or more options differ in effectiveness (the benefits and harms experienced by patients) Project is conducted in a clinical setting that is as close as possible to a real-world setting Methodological approach (including study design, outcome measures, and follow-up) reflects the real-word setting(s) as much as possible without sacrificing scientific rigor 7 What are the qualities of a good PCOR project? PCOR studies should be designed to generate scientifically valid evidence Relevant, testable scientific hypotheses Internal validity required for external validity Adherence to appropriate standards and best practices PCORI Methodology Standards provide guidance for thinking about how to design and conduct a study to answer a CER question 8 4

Design & Analysis Issues in PCOR 9 Choosing a study design: the problem of comparability of groups Confounding: systematic differences between patients receiving alternative interventions Differences in outcomes between the groups of patients may be due to factors other than the treatment received. Example: Studies comparing immediate and delayed use of invasive management in acute cardiac ischemia 10 5

Randomized Controlled Trials (RCTs) Pros: Best way to control for confounding Outcome assessments are tailored Cons: Sample sizes must be large to assess heterogeneity of treatment effects (HTE) Take a long time to complete 11 Observational Studies Pros: Large sample sizes Real-world populations Can be completed quickly Cons: Imperfect methods to control for confounding Outcomes may not be well-defined or hard to assess 12 6

Sources of data in clinical research projects: observational studies Prospective Registries (prospective cohort) The registry is designed prior to data collection and often before defining the research question Records data on both receipt of services and outcomes Controls methods for selection of participants and collection of data May not be perfectly aligned with goals of a specific research question Require a long time to complete patient follow-up Retrospective Cohorts The research question is identified prior to constructing the registry Built upon existing data sources Includes people who were identified and treated in the past Imperfect identification of participants Timing of data collection is problematic Quicker and much less expensive 13 Other sources of data for clinical research projects Administrative Databases Data inherently collected for non-research purposes Often require merging of datasets Patient matching Different clinical systems Potential for very large datasets Does size outweigh the limitations? 14 7

Choosing the right outcomes Identify the most important benefits and harms Value of engagement with clinical and patient partners Patient-reported outcomes (PROs) Can be tailored to those outcomes that are important to patients May require significant infrastructure to obtain these measures Issues of validity of measurement instruments Time course of measurement Is the follow-up sufficiently long? 15 Other considerations for choosing outcomes Potential sources of bias Testing effects Frequent measurement of patient-reported outcomes Respondent fatigue Measuring too many outcomes Careful selection and measurement of process variables for estimating treatment effects Outcomes that may not be considered patient-centered may still be important for ensuring validity and reliability of results 16 8

Causal inference in PCOR Causal Model Informed by the PICOTS framework Represents the key variables, known or hypothesized relationships among them, and conditions under which the hypotheses are to be tested Internal Validity Valid estimates of treatment effects in the study population External Validity Generalizability of results to patients not included in the study population 17 Choosing appropriate statistical methods Missing data Particular challenge in PCOR Understanding the missing data mechanisms Sensitivity analyses Confounding Not necessarily eliminated by randomization Measured vs. unmeasured confounding Statistical approaches rely on assumptions, not all of which are testable Heterogeneity of Treatment Effects (HTE) Justification and pre-specification of HTE analyses Hypothesis-driven (confirmatory) vs. hypothesis-generating (exploratory) 18 9

PCORI Works to Improve Research Methodology In any study, methods matter. That s why we ve developed methodology standards that all research should follow, at a minimum. Methodology Standards: 11 Broad Categories Formulating Research Questions Patient-Centeredness Data Integrity and Rigorous Analyses Preventing/Handling Missing Data Heterogeneity of Treatment Effects Data Networks Data Registries Adaptive and Bayesian Trial Designs Causal Inference Studies of Diagnostic Tests Systematic Reviews 19 Conclusions The starting point of all PCOR is to define important healthcare decisions that need better evidence. The ending point of all PCOR is the generation of results that are useful to decision makers. The choice of study design, data source(s), and analytical methods affects the quality and strength of evidence generated by a study. 20 10

Questions? Thank You David Hickam, MD, MPH Director, Clinical Effectiveness & Decision Science Program dhickam@pcori.org 11